Hunan Jiudian Pharmaceutical Co., Ltd.

SZSE:300705.SZ

24.47 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 696.028784.788779.699766.427584.043790.032675.218715.842501.873727.041568.213581.899449.063498.065397.864453.63278.106321.335263.532232.827160.466264.587233.336247.706178.432240.04200.767191.947168.621184.577134.877125.23589.826121.74893.09880.77765.1279.39779.39765.84965.84970.01870.01863.22663.226
Cost of Revenue 183.927221.324196.122212.706161.666206.56145.526145.144125.939175.332120.854132.47493.862113.35681.14992.60562.7982.37760.21553.07150.3676.43769.87988.31565.91693.01777.50380.12273.03779.29868.06463.26846.28557.68644.99540.20433.70738.59138.59131.56731.56732.9632.54131.46831.468
Gross Profit 512.102563.464583.577553.721422.377583.472529.692570.698375.935551.709447.359449.425355.201384.708316.715361.025215.316238.958203.317179.756110.105188.15163.458159.391112.516147.023123.264111.82595.584105.2866.81261.96743.54164.06248.10340.57431.41340.80640.80634.28234.28237.05837.47731.75931.759
Gross Profit Ratio 0.7360.7180.7480.7220.7230.7390.7840.7970.7490.7590.7870.7720.7910.7720.7960.7960.7740.7440.7720.7720.6860.7110.7010.6430.6310.6120.6140.5830.5670.570.4950.4950.4850.5260.5170.5020.4820.5140.5140.5210.5210.5290.5350.5020.502
Reseach & Development Expenses 63.10678.53853.42468.88340.92892.34766.34548.4142.59872.73144.62149.61934.2955.55434.89731.96123.8522.0125.07419.63914.95431.81431.66231.45414.8720.89317.729.8587.94538.3756.66412.095018.06900000007.6360.8550.8550.855
General & Administrative Expenses 28.565-19.17540.699-1.19519.7-25.37950.297-3.22519.36221.05538.178-4.76210.849-19.07327.057-4.5669.963-17.2099.542-3.0278.151-13.9418.047-3.1038.357-9.6086.332-9.16313.997-16.4410.895-7.1089.916-17.2338.5787.9378.19810.97210.9728.838.8310.84111.7093.7013.701
Selling & Marketing Expenses 271.128268.626358.035306.941239.316425.687288.418361.728231.599401.772290.221289.856237.781264.728202.542232.73132.113170.166143.524117.80177.764129.656103.06799.71976.14685.24180.09276.36763.23756.80130.74833.53421.10323.4325.74421.79814.64618.89818.89811.70511.70515.66115.50113.43913.439
SG&A 299.693249.451331.511323.76253.036458.585338.715358.502250.961428.564328.4285.095248.63245.655229.599228.164142.076152.957153.066114.77485.915115.715111.11496.61684.50375.63386.42467.20477.23440.36241.64326.42631.0196.19734.32229.73622.84429.8729.8720.53520.53527.26227.2117.13917.139
Other Expenses 4.13168.3999.024-0.251-2.542-4.405-0.5169.5860.013-9.84-0.6520.175-0.1050.708-0.704-0.5180.872-0.035-0.618-0.2290.003-2.671-1.017-0.3920.083-2.3460.7350.5660.2020.2141.372-0.2520.8461.264-0.26200.59500000000
Operating Expenses 366.929496.387393.959392.893296.506555.337384.253441.176289.977491.455357.658356.648287.339330.774249.949280.517159.262201.479176.057146.372101.079165.272144.454141.758100.174114.281106.77896.27279.38680.43843.11544.34132.03235.53235.06230.55123.31829.7929.7920.53620.53627.41328.33917.32717.327
Operating Income 145.17267.077189.618160.828125.87128.136142.627126.89985.86160.25484.82883.80562.42137.94762.6571.64453.59131.48624.69728.2657.27219.37916.80115.76510.95132.88316.55315.64915.16224.44422.56516.40511.42529.00912.6710.1557.69310.23910.23913.16413.1648.8579.82813.82213.822
Operating Income Ratio 0.2090.0850.2430.210.2160.0360.2110.1770.1710.0830.1490.1440.1390.0760.1570.1580.1930.0980.0940.1210.0450.0730.0720.0640.0610.1370.0820.0820.090.1320.1670.1310.1270.2380.1360.1260.1180.1290.1290.20.20.1260.140.2190.219
Total Other Income Expenses Net -2.039-0.642-0.5160.029-1.661-1.292-0.5169.5860.013-0.506-0.6520.175-0.1050.708-0.704-0.5180.872-0.035-0.618-0.2290.003-2.671-1.017-0.3920.083-2.3460.7350.5660.2020.2481.361-0.2760.8461.213-0.2830.4530.5950.7770.7771.0151.0150.9130.8830.4050.405
Income Before Tax 143.13466.434189.102171.028145.6337.691142.111136.48485.87459.74884.17683.9862.31638.65561.94671.12754.46331.45124.07928.0367.27516.70815.78415.37211.03430.53717.28816.21615.36524.69323.92716.12912.2730.22212.38710.0238.28811.01611.01613.74713.7479.7699.76914.22714.227
Income Before Tax Ratio 0.2060.0850.2430.2230.2490.0480.210.1910.1710.0820.1480.1440.1390.0780.1560.1570.1960.0980.0910.120.0450.0630.0680.0620.0620.1270.0860.0840.0910.1340.1770.1290.1370.2480.1330.1240.1270.1390.1390.2090.2090.140.140.2250.225
Income Tax Expense 17.3583.79223.49712.56719.961-20.57929.74915.7468.9841.5635.55410.1796.353.6215.5514.7578.0154.3771.7152.3250.164-0.5016.448-2.7320.6172.9720.7831.0932.5712.4722.1611.6882.1244.0780.8861.5821.5730.3640.3642.0772.0771.231.232.1512.151
Net Income 125.77662.642165.604158.461125.66958.27112.362120.73876.89161.31178.62273.80155.96635.03456.39566.36946.44727.07422.36425.7117.11117.2099.33618.10410.41627.56416.50515.12212.79322.22121.76614.44110.14626.14511.5018.4416.71510.65210.65211.6711.678.5438.54312.07612.076
Net Income Ratio 0.1810.080.2120.2070.2150.0740.1660.1690.1530.0840.1380.1270.1250.070.1420.1460.1670.0840.0850.110.0440.0650.040.0730.0580.1150.0820.0790.0760.120.1610.1150.1130.2150.1240.1040.1030.1340.1340.1770.1770.1220.1220.1910.191
EPS 0.250.1260.340.330.360.170.330.350.220.140.240.220.170.0760.120.20.140.0550.0710.0570.0210.0350.0290.0430.0290.0620.050.0310.0430.0460.0930.040.0430.0760.0460.050.0290.0650.0650.0730.0730.0270.30.0380.038
EPS Diluted 0.250.1260.340.330.360.170.330.350.220.140.240.220.170.0760.120.20.140.0550.0710.0570.0210.0350.0290.0430.0290.0620.050.0310.0430.0460.0930.040.0430.0760.0460.050.0290.0650.0650.0730.0730.0270.30.0380.038
EBITDA 146.34469.552194.21198.722147.41363.356164.858154.18103.29250.449104.257104.41482.50257.79581.04989.07668.72144.89537.63541.60318.06628.75623.63124.72817.19131.07120.33515.93217.75824.86226.89717.40211.50829.91813.04113.1988.24613.1913.1915.70215.70212.97214.09216.3416.34
EBITDA Ratio 0.210.0890.2490.2590.2520.080.2440.2150.2060.0690.1830.1790.1840.1160.2040.1960.2470.140.1430.1790.1130.1090.1010.10.0960.1290.1010.0830.1050.1350.1990.1390.1280.2460.140.1630.1270.1660.1660.2380.2380.1850.2010.2580.258